NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CSW Industrials, Inc. (NASDAQ: CSWI ), Cavco Industries, Inc. (NASDAQ: CVCO ), Intra-Cellular Therapies Inc. (NASDAQ: ITCI ), Atrion Corporation (NASDAQ: ATRI ), QAD Inc. (NASDAQ: QADA ), and A V Homes, Inc. (NASDAQ: AVHI ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CSWI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CSWI CVCO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVCO ITCI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ITCI ATRI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ATRI QADA DOWNLOAD: http://Fundamental-Markets.com/register/?so=QADA AVHI DOWNLOAD: http://Fundamental-Markets.com/register/?so=AVHI
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine CSW Industrials, Inc. (NASDAQ: CSWI ), Cavco Industries, Inc. (NASDAQ: CVCO ), Intra-Cellular Therapies Inc. (NASDAQ: ITCI ), Atrion Corporation (NASDAQ: ATRI ), QAD Inc. (NASDAQ: QADA ), and A V Homes, Inc. (NASDAQ: AVHI ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CSW INDUSTRIALS, INC. (CSWI) REPORT OVERVIEW
CSW Industrials' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, CSW Industrials reported revenue of $69.04MM vs $65.26MM (up 5.79%) and basic earnings per share -$2.17 vs $0.03. For the twelve months ended March 31st, 2017 vs March 31st, 2016, CSW Industrials reported revenue of $327.08MM vs $319.83MM (up 2.27%) and basic earnings per share $0.70 vs $1.63 (down 57.06%). CSW Industrials is expected to report earnings on May 30th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.43.
To read the full CSW Industrials, Inc. (CSWI) report, download it here: http://Fundamental-Markets.com/register/?so=CSWI
-----------------------------------------
CAVCO INDUSTRIES, INC. (CVCO) REPORT OVERVIEW
Cavco Industries' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Cavco Industries reported revenue of $221.38MM vs $202.31MM (up 9.43%) and basic earnings per share $2.37 vs $1.37 (up 72.99%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, Cavco Industries reported revenue of $773.80MM vs $712.35MM (up 8.63%) and basic earnings per share $4.23 vs $3.21 (up 31.78%). Cavco Industries is expected to report earnings on May 29th, 2018. The report will be for the fiscal period ending March 31st, 2018.
To read the full Cavco Industries, Inc. (CVCO) report, download it here: http://Fundamental-Markets.com/register/?so=CVCO
-----------------------------------------
INTRA-CELLULAR THERAPIES INC. (ITCI) REPORT OVERVIEW
Intra-Cellular Therapies' Recent Financial Performance
For the twelve months ended December 31st, 2017 vs December 31st, 2016, Intra-Cellular Therapies reported revenue of $0.25MM vs $0.33MM (down 25.67%) and basic earnings per share -$2.12 vs -$2.69. Intra-Cellular Therapies is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$3.42 and is expected to report on March 7th, 2019.
To read the full Intra-Cellular Therapies Inc. (ITCI) report, download it here: http://Fundamental-Markets.com/register/?so=ITCI
-----------------------------------------
ATRION CORPORATION (ATRI) REPORT OVERVIEW
Atrion's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Atrion reported revenue of $39.40MM vs $38.50MM (up 2.33%) and basic earnings per share $4.58 vs $5.42 (down 15.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Atrion reported revenue of $146.60MM vs $143.49MM (up 2.17%) and basic earnings per share $19.82 vs $15.12 (up 31.08%). Atrion is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018.
To read the full Atrion Corporation (ATRI) report, download it here: http://Fundamental-Markets.com/register/?so=ATRI
-----------------------------------------
QAD INC. (QADA) REPORT OVERVIEW
QAD's Recent Financial Performance
For the three months ended January 31st, 2018 vs January 31st, 2017, QAD reported revenue of $80.75MM vs $73.26MM (up 10.22%) and basic earnings per share -$0.26 vs -$0.80. For the twelve months ended January 31st, 2018 vs January 31st, 2017, QAD reported revenue of $305.02MM vs $277.97MM (up 9.73%) and basic earnings per share -$0.47 vs -$0.82. QAD is expected to report earnings on May 30th, 2018. The report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is $0.04 and is expected to report on March 20th, 2019.
To read the full QAD Inc. (QADA) report, download it here: http://Fundamental-Markets.com/register/?so=QADA
-----------------------------------------
A V HOMES, INC. (AVHI) REPORT OVERVIEW
A V Homes' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, A V Homes reported revenue of $152.01MM vs $155.55MM (down 2.28%) and basic earnings per share -$0.10 vs $0.11. For the twelve months ended December 31st, 2017 vs December 31st, 2016, A V Homes reported revenue of $843.25MM vs $779.31MM (up 8.21%) and basic earnings per share -$0.98 vs $6.58. A V Homes is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $1.40 and is expected to report on February 28th, 2019.
To read the full A V Homes, Inc. (AVHI) report, download it here: http://Fundamental-Markets.com/register/?so=AVHI
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
